|
 |
|
 |
|
Acomplia Sanofi-Aventis |
Acomplia is a Sanofi-Aventis product which was developed as a result of 2 years of clinical trials. Sanofi- Aventis is a French pharmaceutical company, which indulges in development, research, manufacturing and marketing exclusively in the prescription market. This drug company was formed in 2004, when Sanofi- Synthélabo was merged with Aventis as a result of interference by the French government.
Weight loss product Acomplia is a film-coated tablet which is to be used in consonance with a proper diet plan and regular workout regime to achieve desired results. Appropriate precautionary measures should be pursued while using this diet pill in order to get the maximum benefits.
Diet pill Acomplia, is accessible in the strengths of 20mg and 10mg. Acomplia tablets come blister packaging, and are solely saleable on prescription.
This medication is not intended for pregnant women, breast-feeding mothers, women with child bearing potential, diabetics, heart patients, individuals under the age group of 18 years. Consult a medical professional prior to initiating this weight loss treatment.
It has been approved for sale in the UK, France, Austria, Finland, Switzerland, Germany, Mexico, Argentina, Brazil, and even the UAE. Despite being approved for sale in several European and Latin-American countries, it has not yet been made available in the US due to stalled FDA's endorsement.
|
|
|
 |
|
 |
|
|
|
|
